Furthermore, a study of normal tissue and matched primary tumors from 13 CRC patients showed that the ABCG2 mRNA was decreased six-fold in cancer tissue compared to matched normal CRC mucosa. This evidence concerns the gene ABCG2 and colorectal carcinoma.